# BIS-PEG-12 DIMETHICONE (bis-peg-12-dimethicone) — Global Cosmetic Regulatory & Formulation Monograph

- **Canonical URL**: https://www.inciname.com/en/ingredients/bis-peg-12-dimethicone
- **Standard INCI**: `BIS-PEG-12 DIMETHICONE`
- **KR MFDS Standard Name**: `비스-피이지-12다이메티콘`
- **CAS No.**: `102783-01-7`
- **EC / EINECS No.**: `N/A`
- **Origin**: `synthetic`
- **Functions**: 모발컨디셔닝제, 피부컨디셔닝제, 에모리엔트
- **Molecular Formula / MW**: `—` (— g/mol)

## 1. 7-Track Official Regulatory Label Names
| Track | Official Label Nomenclature |
| :--- | :--- |
| KR (MFDS Standard) | 비스-피이지-12다이메티콘 |
| KR (Former Names) | — |
| EU (CosIng 1223/2009) | BIS-PEG-12 DIMETHICONE |
| US (PCPC / MoCRA INCI) | BIS-PEG-12 DIMETHICONE |
| US (FDA OTC Monograph) | — |
| CN (NMPA IECIC) | 双-PEG-12 聚二甲基硅氧烷 |
| JP (JCIA / MHLW QD) | BIS-PEG-12 DIMETHICONE  |

## 2. Layer 1 — Global 6-Region Statutory Summary
- **KR (MFDS)**: `none`
- **EU (1223/2009)**: `none`
- **US (FDA/MoCRA)**: `none`
- **CN (NMPA IECIC)**: `allowed` (Entry: `6210`)
- **JP (MHLW)**: `none`
- **ASEAN (ACD)**: `none`



## 3. Layer 2 — Toxicological & Historical Safe Use Concentrations
- Listed within general cosmetic GMP safety thresholds.

## 4. Layer 3 — Formulation Quartiles & Compatibility
- **Optimal pH Window**: 4 – 8
- **Max Process Temp**: ≤ 50°C
- **Synergy Pairings**: GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL
- **Incompatibilities**: Verify phase compatibility under extreme pH or high electrolyte loads

## 5. Academic Monograph
■ [1. Chemical Identity & International Labeling Nomenclature]
  - INCI Name: BIS-PEG-12 DIMETHICONE | CAS No.: 102783-01-7 | EC No.: N/A
  - Origin: SYNTHETIC | Functions: , , 
  - Physicochemical Profile: Formula      | MW /(Polymer/Complex) | /   | Ionic Nature: non-ionic | CosIng/MFDS 
  - Official Regional Label Names: US [BIS-PEG-12 DIMETHICONE] · EU [BIS-PEG-12 DIMETHICONE] · CN [双-PEG-12 聚二甲基硅氧烷] · JP [-] · JP Quasi-Drug [-]
■ [2. Dermatological Mechanism of Action & Functional Role]
  - Bis-PEG-12 Dimethicone is Dimethicone end-blocked with average of 12 moles of ethylene oxide Classified under origin 'synthetic', it acts within the cosmetic vehicle or stratum corneum to deliver , ,  performance and structural formulation stability.
■ [3. Global 6-Jurisdiction Regulatory Status & Safety Limits (Layer 1 & Layer 2)]
  - Regional Summary: KR: NONE | EU: NONE | US: NONE | CN: ALLOWED | JP: NONE | ASEAN: NONE (CN IECIC (2025) Entry No. 6210 (双-PEG-12 聚二甲基硅氧烷))
  - No specific Annex prohibition or numeric restriction across the 6 major jurisdictions (Permitted under general GMP safety assessment).
  - Official Safety & Historical Use Concentration (Layer 2): Quantum satis (QS) within standard cosmetic safety margins
■ [4. Formulation Dosage Guide by Product Category (Layer 3-A)]
  - [aqueous_serum] Typical range: 3.0 ~ 20.0% (Median 4.0%, Ref: Global Starter Formulation Library Statistical Distribution (n=6, GRANT 6)) — Aqueous serum, toner & hydrogel matrix formulation component
  - [cleanser_rinse] Typical range: 1.0 ~ 10.0% (Median 2.0%, Ref: Global Starter Formulation Library Statistical Distribution (n=7, GRANT 7)) — Rinse-off cleanser & surfactant system modifier
■ [5. Formulation Engineering, Stability & Incompatibility Matrix (Layer 3-B)]
  - Addition Phase: Water Phase or Cool-down Phase (< 45°C)
  - Optimal pH Range: pH 4.0 ~ 8.0 | Max Process Temp: Max 50°C | Electrolyte Tolerance: MEDIUM
  - Incompatibility / Caution: Verify phase compatibility under extreme pH or high electrolyte loads
  - Synergy Pairings: GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL | Reference Trade Names: BIS-PEG-12 DIMETHICONE
■ [6. Peer-Reviewed Literature & Official Compendia Evidence]
  - PMID 42019729 (2026, J Am Acad Dermatol): Plastic in dermatology: Impacts on human health, skin disease, and the contribution of personal care product use to envi
  - PMID 41835609 (2026, ACS Omega): Tailoring the Stability of W/O/W Liquid Foundations: A Comparative Study of Polyglycerol-Based W/O Emulsifiers
  - PMID 41373051 (2025, J Dent Child (Chic)): Fluoride Release, Enamel Fluoride Uptake and Dentin Tubule Occlusion From A Novel Dimethicone-Based Fluoride Varnish

## 6. Linked PubMed Literature
- [PMID: 42019729] Plastic in dermatology: Impacts on human health, skin disease, and the contribution of personal care product use to environmental pollution — *J Am Acad Dermatol* (2026)
- [PMID: 41835609] Tailoring the Stability of W/O/W Liquid Foundations: A Comparative Study of Polyglycerol-Based W/O Emulsifiers — *ACS Omega* (2026)
- [PMID: 41373051] Fluoride Release, Enamel Fluoride Uptake and Dentin Tubule Occlusion From A Novel Dimethicone-Based Fluoride Varnish — *J Dent Child (Chic)* (2025)
- [PMID: 40643063] Skin cleansers and leave-on product interventions for preventing incontinence-associated dermatitis in adults — *Cochrane Database Syst Rev* (2025)
- [PMID: 40333845] Cleansing Mechanisms and Efficacy on Artificial Skin — *Molecules* (2025)
- [PMID: 39741562] The Role of Moisturizer Containing Anti-inflammatory on Skin Hydration in Mild-Moderate Atopic Dermatitis Patients — *Dermatol Res Pract* (2024)
- [PMID: 39684059] Structural Similarity-Induced Inter-Component Interaction in Silicone Polymer-Based Composite Sunscreen Film for Enhanced UV Protection — *Polymers (Basel)* (2024)
- [PMID: 39588819] Characteristics of Diaper Dermatitis in Patients Aged 0-24 Months After Congenital Heart Disease and the Effects of a Diaper Dermatitis Care Bundle: A Comparison of 2 Groups — *J Wound Ostomy Continence Nurs* (2024)
- [PMID: 39564575] A New Prescription Emollient Device (PED) For Psoriasis of Sensitive Areas and Folds: A Randomized Prospective Open Trial — *Psoriasis (Auckl)* (2024)
- [PMID: 39349693] Impact of Different Packaging Configurations on A Topical Cream Product — *Pharm Res* (2024)
- [PMID: 39045851] Safety Assessment of Vinylpyrrolidone Polymers as Used in Cosmetics — *Int J Toxicol* (2024)
- [PMID: 39042700] A pilot study of dimeticone oils versus sodium carbonate treatment for tungiasis: A randomized cohort trial in Homa Bay County, Kenya — *PLoS Negl Trop Dis* (2024)
